Atea Pharmaceuticals
Atea Pharmaceuticals Logo
About Atea Pharmaceuticals
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of oral direct-acting antiviral therapies for serious viral infections. The company is advancing innovative treatments targeting single-stranded RNA viruses, including hepatitis C virus (HCV) and COVID-19. Its lead product candidates include bemnifosbuvir (AT-527) and ruzasvir, which are being evaluated in global clinical trials. Atea Pharmaceuticals collaborates with partners to address unmet medical needs and aims to transform the treatment landscape for viral diseases.
Address
225 Franklin Street, Suite 2100
Boston, 02110
United States
Year founded
2012
Number of employees
0-100
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
